Trehalose/Hyaluronic acid

N/A

Report date: 2022/10/19 15:11:55

Base Information

Drug NameTrehalose/Hyaluronic acid
Drug Alias NameHyaluronic acid/TrehaloseTrehalose+Hyaluronic acidHyaluronic acid+TrehaloseT-2762
ClassificationSmall molecules
Mechanisms of ActionCD44 antigen modulators
TargetsCD44 antigen
Therapy Area/IndicationsDry Eye Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Thea SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratoires Thea SAS
Active IndicationsN/A
Inactive IndicationsDry Eye Syndromes

Other Information

ATC CodeN/A
Related LinksN/A